TGFBR2 and prostate carcinoma: In this line, Mishra et al. using prostate cancer model showed that miR-21 is an androgen-responsive miRNA that could attenuate the expression of TGFBR2, and AR is the key mediator of androgen effects on the expression of miR-2137.